Aberrant Receptor Internalization and Enhanced FRS2-dependent Signaling Contribute to the Transforming Activity of the Fibroblast Growth Factor Receptor 2 IIIb C3 Isoform*

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Biological Chemistry

• Publication date

  2009-03-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1074/jbc.M803998200PMID 19103595PMCID PMC2649112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involvement of Fibroblast Growth Factor Receptor 2 Isoform Switching in Mammary Oncogenesis

  2008cited by this paper
• Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes

  2007cited by this paper
• Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells

  2007cited by this paper
• Binding of Cbl to a phospholipase Cgamma1-docking site on platelet-derived growth factor receptor beta provides a dual mechanism of negative regulation.

  2007cited by this paper
• Binding of Cbl to a Phospholipase Cγ1-docking Site on Platelet-derived Growth Factor Receptor β Provides a Dual Mechanism of Negative Regulation*

  2007cited by this paper
• MAPK signal specificity: the right place at the right time.

  2006cited by this paper
• Cell cycle: sustained ERK signalling represses the inhibitors.

  2006cited by this paper
• Mechanisms underlying differential responses to FGF signaling.

  2005cited by this paper
• Cellular signaling by fibroblast growth factor receptors.

  2005cited by this paper
• Fibroblast growth factor signaling in tumorigenesis.

  2005cited by this paper
• Tyrosine 769 of the keratinocyte growth factor receptor is required for receptor signaling but not endocytosis.

  2005cited by this paper
• Recognition of the Tryptophan-based Endocytosis Signal in the Neonatal Fc Receptor by the μ Subunit of Adaptor Protein-2*

  2005cited by this paper
• Structural basis for fibroblast growth factor receptor activation.

  2005cited by this paper
• Evolution of the Fgf and Fgfr gene families.

  2004cited by this paper
• Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.

  2004cited by this paper
• Constitutively activated FGFR3 mutants signal through PLCgamma-dependent and -independent pathways for hematopoietic transformation.

  2004cited by this paper
• Defective downregulation of receptor tyrosine kinases in cancer

  2004cited by this paper
• Common and Distinct Elements in Cellular Signaling via EGF and FGF Receptors

  2004cited by this paper
• Negative receptor signalling.

  2003cited by this paper
• Signals for sorting of transmembrane proteins to endosomes and lysosomes.

  2003cited by this paper
• The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors.

  2002cited by this paper
• Tryptophan- and Dileucine-based Endocytosis Signals in the Neonatal Fc Receptor*

  2001cited by this paper
• Regulation of phosphoinositide-specific phospholipase C.

  2001cited by this paper
• Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins

  2001cited by this paper
• FRS2 Proteins Recruit Intracellular Signaling Pathways by Binding to Diverse Targets on Fibroblast Growth Factor and Nerve Growth Factor Receptors

  2000cited by this paper
• A tyrosine‐based sorting signal in the β2 integrin cytoplasmic domain mediates its recycling to the plasma membrane and is required for ligand‐supported migration

  1999cited by this paper
• Characterization of Recombinant Human Fibroblast Growth Factor (FGF)-10 Reveals Functional Similarities with Keratinocyte Growth Factor (FGF-7)*

  1998cited by this paper
• Overexpression of phosphoinositide-specific phospholipase Cgamma in NIH 3T3 cells promotes transformation and tumorigenicity.

  1998cited by this paper
• Platelet-derived Growth Factor-dependent Cellular Transformation Requires Either Phospholipase Cγ or Phosphatidylinositol 3 Kinase*

  1997cited by this paper
• A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway.

  1997cited by this paper
• The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor.

  1997cited by this paper
• Overexpression of phospholipase C-gamma1 in rat 3Y1 fibroblast cells leads to malignant transformation.

  1997cited by this paper
• Structure and Expression of the Rat mRNA Encoding a Novel Member of the Fibroblast Growth Factor Family*

  1996cited by this paper
• Keratinocyte growth factor is a bifunctional regulator of HPV16 DNA- immortalized cervical epithelial cells

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity.

  1994cited by this paper
• FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions.

  1994cited by this paper
• Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2).

  1993cited by this paper
• Ligand-induced internalization of the epidermal growth factor receptor is mediated by multiple endocytic codes analogous to the tyrosine motif found in constitutively internalized receptors.

  1993cited by this paper
• Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene.

  1992cited by this paper
• Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis

  1992cited by this paper
• Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin.

  1992cited by this paper
• Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis

  1992cited by this paper
• A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.

  1992cited by this paper
• A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

  1992cited by this paper
• Localization of the signal for rapid internalization of the bovine cation-independent mannose 6-phosphate/insulin-like growth factor-II receptor to amino acids 24-29 of the cytoplasmic tail.

  1991cited by this paper
• A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1

  1991cited by this paper
• Evidence that UTP and ATP regulate phospholipase C through a common extracellular 5'-nucleotide receptor in human airway epithelial cells.

  1991cited by this paper
• Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop.

  1991cited by this paper
• Purification and characterization of a newly identified growth factor specific for epithelial cells.

  1989cited by this paper
• Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

  1989cited by this paper

• Proteome-Wide Analysis of Functional Phosphosites in the FGFR Family of Proteins: Insights from Large-Scale Phosphoproteomic Analysis.

  2026cites this paper
• Unraveling the FGFR–RNA splicing axis: Mechanisms, oncogenic crosstalks and innovations for therapeutic purpose

  2025cites this paper
• The C-terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

  2025cites this paper
• M2 Macrophage Polarization Mediated by Complement C3 from Hedgehog-Activated Fibroblasts Establishes an Immunosuppressive Niche in Gastric Cancer

  2025cites this paper
• Development and disease-specific regulation of RNA splicing in cardiovascular system

  2024cites this paper
• Clinical Value of Liquid Biopsy in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma During Targeted Therapy

  2024cites this paper
• Case report: High-grade serous tubo-ovarian carcinoma with FGFR2::IQCG fusion and insights into targetability

  2024cites this paper
• To Investigate Growth Factor Receptor Targets and Generate Cancer Targeting Inhibitors.

  2023cites this paper
• RLY-4008, the First Highly Selective FGFR2 Inhibitor with Activity across FGFR2 Alterations and Resistance Mutations

  2023cites this paper
• Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas

  2023cites this paper
• Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration

  2022cites this paper
• Bioinformatics Analysis of C3 in Brain Low Grade Gliomas as Potential Therapeutic Target and Promoting Immune Cell In�ltration

  2022cites this paper
• Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing

  2022cites this paper
• Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

  2022cites this paper
• Chimeric transcripts observed in non-canonical FGFR2 fusions with partner genes' breakpoint located in intergenic region in intrahepatic cholangiocarcinoma.

  2022cites this paper
• Validation and Characterization of FGFR2 Rearrangements in Cholangiocarcinoma With Comprehensive Genomic Profiling.

  2022cites this paper
• Negative Regulation of FGFR (Fibroblast Growth Factor Receptor) Signaling

  2021cites this paper
• 2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology

  2021cites this paper
• Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis

  2020cites this paper
• Fibroblast growth factor signalling in osteoarthritis and cartilage repair

  2020cites this paper
• Clinicogenomic analysis of FGFR2-rearranged cholangiocarcinoma identifies correlates of response and mechanisms of resistance to pemigatinib.

  2020cites this paper
• Molecular detection and clinicopathological characteristics of advanced/recurrent biliary tract carcinomas harboring the FGFR2 rearrangements: a prospective observational study (PRELUDE Study)

  2020cites this paper
• Reciprocal regulation of the Fibroblast Growth Factor Receptor 2 (FGFR2) and the Transient Receptor Potential Ankyrin 1 (TRPA1) through their direct interaction

  2019cites this paper
• Fibroblast Growth Factor Receptor Inhibitors: Enhancing Therapeutic Strategies for Solid Tumors

  2019cites this paper
• Alternative Splicing in Angiogenesis

  2019influential citation
• Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1/2 Pathway

  2019cites this paper
• Functions of FGFR2 corrupted by translocations in intrahepatic cholangiocarcinoma.

  2019cites this paper
• An integrated approach to infer cross-talks between intracellular protein transport and signaling pathways

  2018cites this paper
• Identification and Therapeutic Intervention of Co-activated ALK , FGFR 2 and EphA 5 Kinases in Hepatocellular Carcinoma

  2018cites this paper
• Interplay between FGFR2b‐induced autophagy and phagocytosis: role of PLCγ‐mediated signalling

  2017cites this paper
• Linked read sequencing resolves complex genomic rearrangements in gastric cancer metastases

  2017cites this paper
• Challenges and future of biomarker tests in the era of precision oncology: Can we rely on immunohistochemistry (IHC) or fluorescence in situ hybridization (FISH) to select the optimal patients for matched therapy?

  2017cites this paper
• Targeting the fibroblast growth factor receptor 2 in gastric cancer: promise or pitfall?

  2017cites this paper
• Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models.

  2016cites this paper
• Roles of FGFR in oral carcinogenesis

  2016cites this paper
• The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer

  2016cites this paper
• Development and application of high-field asymmetric waveform ion mobility spectrometry and mass spectrometry for the investigation of fibroblast growth factor signalling

  2016cites this paper
• Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies

  2016cites this paper
• University of Dundee The heparan sulfate sulfotransferase 3-OST3A (HS3ST3A) is a novel tumor regulator and a prognostic marker in breast cancer

  2016cites this paper
• Phenotypic and Signaling Consequences of a Novel Aberrantly Spliced Transcript FGF Receptor-3 in Hepatocellular Carcinoma.

  2016cites this paper
• High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial.

  2016cites this paper
• FGFR2 mutation in a Chinese family with unusual Crouzon syndrome.

  2016cites this paper
• Targeting the fibroblast growth factor receptor family in cancer.

  2016influential citation
• FIBROBLAST GROWTH FACTOR RECEPTOR IN CANCER

  2015cites this paper
• COMPETITION BETWEEN GRB2 AND PLCγ1 FOR BINDING TO FGFR2 REGULATES PHOSPHOLIPASE AND PTEN ACTIVITY, LEADING TO CELL INVASION AND PROLIFERATION

  2014cites this paper
• PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

  2014cites this paper
• PDGFR b and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

  2014cites this paper
• DISCOVERY AND ELUCIDATION OF THE FGFR3-TACC3 RECURRENT FUSION IN GLIOBLASTOMA

  2014cites this paper
• Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion

  2014cites this paper
• Isoforms of Receptors of Fibroblast Growth Factors

  2014cites this paper
• Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.

  2013cites this paper
• Identification of targetable FGFR gene fusions in diverse cancers.

  2013cites this paper
• Functional roles of fibroblast growth factor receptors (FGFRs) signaling in human cancers

  2013cites this paper
• Novel regulators of cell migration

  2013cites this paper
• ERK-Mediated Phosphorylation of Fibroblast Growth Factor Receptor 1 on Ser777 Inhibits Signaling

  2013cites this paper
• Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity

  2013cites this paper
• Structure-Function Relationship of the Ligand-Binding Domain of the Fibroblast Growth Factor Receptor

  2013cites this paper
• Relative expression of fibroblast growth factor receptors in feline sarcomas

  2012cites this paper
• Molecular Pathways Molecular Pathways : Fibroblast Growth Factor Signaling : A New Therapeutic Opportunity in Cancer

  2012cites this paper
• Mutant p63 causes defective expansion of ectodermal progenitor cells and impaired FGF signalling in AEC syndrome

  2012cites this paper
• Inhibition of basal FGF receptor signaling by dimeric Grb2.

  2012cites this paper
• Mechanisms of FGFR-mediated carcinogenesis.

  2012cites this paper
• Challenges and opportunities in the targeting of fibroblast growth factor receptors in breast cancer

  2012cites this paper
• The Role of Alternatively spliced Fibroblast Growth Factor Receptor 2 Isoforms in Breast Cancer

  2012cites this paper
• The Receptor Tyrosine Kinase FGFR2b/KGFR Controls Early Differentiation of Human Keratinocytes

  2011cites this paper
• Expression and signaling of the tyrosine kinase FGFR2b/KGFR regulates phagocytosis and melanosome uptake in human keratinocytes

  2011cites this paper
• Tricyclic Antidepressant Amitriptyline Activates Fibroblast Growth Factor Receptor Signaling in Glial Cells

  2011cites this paper
• Fibroblast growth factors and their receptors in cancer.

  2011cites this paper
• Fibroblast growth factor signalling: from development to cancer

  2010cites this paper
• Roles of Fibroblast Growth Factor Receptors in Carcinogenesis

  2010cites this paper
• Roles of fibroblast growth factor receptors ( FGFRs ) in carcinogenesis

  2010cites this paper
• Mechanism of Phosphorylation-induced Activation of Phospholipase C-γ Isozymes*♦

  2010cites this paper
• Growth Factors as Active Participants in Carcinogenesis: A Perspective

  2009cites this paper
• The FRS2 family of docking/scaffolding adaptor proteins as therapeutic targets of cancer treatment

  2009cites this paper
• RIPRODUZIONE, PRODUZIONE, BENESSERE ANIMALE E SICUREZZA DEGLI ALIMENTI DI ORIGINE ANIMALE

  2009cites this paper
• Challenges and opportunities in the targeting of fi broblast growth factor receptors in breast cancer

  year unknowncites this paper